|
WO2010040120A2
|
|
Prone surgery facial support device
|
|
WO2009151618A2
|
|
Methods and compositions for treating alzheimer's disease
|
|
WO2009038742A2
|
|
Method for estimating risk of acute kidney injury
|
|
WO2008073292A2
|
|
Method for protecting renal tubular epithelial cells from radiocontrast nephro parhy (rcn)
|
|
WO2008127251A1
|
|
Reversible inhibition of pyramidal gap junction activity
|
|
US2007098637A1
|
|
Generation and use of vasculogenic tumors and products derived from same
|
|
WO2007016214A2
|
|
Method for inhibiting tnf-alpha
|
|
US2006105950A1
|
|
Morphogen compositions and use thereof to treat wounds
|
|
CN101072867A
|
|
Novel multipotent stem cells and use thereof
|
|
WO2005028616A2
|
|
Morphogen compositions and methods of use thereof to treat heart disorders
|
|
WO2005002522A2
|
|
Compositions and methods for treating tissue ischemia
|
|
WO2004052914A2
|
|
Compositions and methods for inhibiting malaria protease falcipain-2
|
|
CA2500368A1
|
|
Inhibition of src for treatment of reperfusion injury related to revascularization
|
|
AU2003257960A1
|
|
Cell modulation using a cytoskeletal protein
|
|
US6689807B1
|
|
HMG CoA reductase inhibitors for promoting angiogenesis
|
|
US7125856B1
|
|
Angiogenic growth factors for treatment of peripheral neuropathy
|
|
US7368420B1
|
|
Akt compositions for enhancing survival of cells
|
|
US6676937B1
|
|
Compositions and methods for modulating vascularization
|
